Frank Lee

Frank Lee, PhD, possesses extensive experience in biopharmaceutical development and biologics operations, currently serving as Sr. Director at Eisai US since October 2010. Previously held roles include Director of various departments at both Eisai Inc. and Morphotek Inc., and positions at Johnson & Johnson from April 2002 to October 2010, culminating as Associate Director in API Large Molecule Process Development. Early career experience includes leadership and engineering roles at Laureate Pharma and Regeneron Pharmaceuticals, alongside a postdoctoral fellowship at the University of Colorado at Boulder. Frank Lee earned a PhD in Chemical and Biochemical Engineering from UC Irvine and a BS in Chemical Engineering from National Cheng Kung University.